The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumShort Ideas - Yesterday, Optimer Pharmaceuticals hosted its Analyst Day describing a new lower pricing policy with hospitals to spur demand of Dificid. Our negative view of the … Continue Reading
Read now- Acorda Therapeutics (NASDAQ:ACOR) is trading down Monday on circulation of the September 2012 Formulary Decision Highlights from GroupHealth, a healthcare coordination cooperative. For ACOR’s lead … Continue Reading
Read nowShort Ideas - Optimer Pharmaceuticals (NASDAQ:OPTR) is hosting its Analyst Day in NYC this morning and is detailing its new strategy, which includes lowering the price for lead … Continue Reading
Read now- By Jake King In a press release Monday, BioSante Pharmaceuticals (NASDAQ:BPAX) announced that it will be presenting a corporate update at the BIO Investor Forum … Continue Reading
Read nowLong Ideas - By Jake King Spectrum Pharmaceuticals (NASDAQ:SPPI) announced Monday morning that the company received a five-year extension on its patent for Folotyn, which lengthens the drug’s … Continue Reading
Read nowMost Popular - We continued to add to our Interview collection, posting discussions this past week with the CEO’s of both AdventRx Pharmaceuticals and ARIAD Pharmaceuticals. Our final … Continue Reading
Read nowLong Ideas - Breaking news that health insurer, Oxford Health, will cover HP Acthar Gel (Acthar), looks like a major win for Questcor Pharmaceuticals (NASDAQ:QCOR), and the stock … Continue Reading
Read now
